FI86991B - RECOMBINANT DNA SEQUENCER, DERASE FRAMSTAELLNING OCH DESSA SEQUENTOR INNEHAOLLANDE PLASMIDER. - Google Patents
RECOMBINANT DNA SEQUENCER, DERASE FRAMSTAELLNING OCH DESSA SEQUENTOR INNEHAOLLANDE PLASMIDER.Info
- Publication number
- FI86991B FI86991B FI834700A FI834700A FI86991B FI 86991 B FI86991 B FI 86991B FI 834700 A FI834700 A FI 834700A FI 834700 A FI834700 A FI 834700A FI 86991 B FI86991 B FI 86991B
- Authority
- FI
- Finland
- Prior art keywords
- sequentor
- plasmider
- derase
- innehaollande
- recombinant dna
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
- C12N15/68—Stabilisation of the vector
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
The present invention relates to the combination of the promoter/operator region of the tryptophan operon of Serratia marcescens with a synthetic ribosome binding sequence, an expression plasmid which contains this sequence and in which the above sequence is followed by the only Hind III cleavage site in the plasmid, into which site the gene to be expressed can be inserted, and to production plasmids for the expression of eukaryotic gene products in prokaryotes, especially for the preparation of leucocyte interferon.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19823247922 DE3247922A1 (en) | 1982-12-24 | 1982-12-24 | DNA SEQUENCES, THEIR PRODUCTION, PLASMIDES CONTAINING THESE SEQUENCES AND THE USE THEREOF FOR THE SYNTHESIS OF EUKARYOTIC GENE PRODUCTS IN PROKARYOTS |
DE3247922 | 1982-12-24 |
Publications (4)
Publication Number | Publication Date |
---|---|
FI834700A0 FI834700A0 (en) | 1983-12-21 |
FI834700A FI834700A (en) | 1984-06-25 |
FI86991B true FI86991B (en) | 1992-07-31 |
FI86991C FI86991C (en) | 1992-11-10 |
Family
ID=6181687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI834700A FI86991C (en) | 1982-12-24 | 1983-12-21 | Recombinant DNA sequences, their production and these sequences contain plasmids |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0115613B1 (en) |
JP (2) | JPH088868B2 (en) |
KR (1) | KR930005455B1 (en) |
AT (1) | ATE62018T1 (en) |
AU (1) | AU579991B2 (en) |
DD (1) | DD216043A5 (en) |
DE (2) | DE3247922A1 (en) |
DK (1) | DK576983A (en) |
ES (4) | ES528350A0 (en) |
FI (1) | FI86991C (en) |
GR (1) | GR78766B (en) |
HU (1) | HU202277B (en) |
IL (1) | IL70523A (en) |
MX (1) | MX9202878A (en) |
NO (1) | NO173742C (en) |
NZ (1) | NZ206700A (en) |
SU (2) | SU1366064A3 (en) |
UA (1) | UA8035A1 (en) |
ZA (1) | ZA839519B (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0170204B1 (en) * | 1984-08-01 | 1991-09-25 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Genetic sequences, type i interferon peptide coded by them, and these organisms producing the same |
US6291662B1 (en) | 1984-12-05 | 2001-09-18 | Amgen Inc. | Recombinant methods for production of serine protease inhibitors and DNA sequences |
HU204563B (en) * | 1984-12-06 | 1992-01-28 | Synergen Biolog Inc | Process for producing recombinant serine-protease inhibitors and dns sequencyes for them |
FI90990C (en) * | 1984-12-18 | 1994-04-25 | Boehringer Ingelheim Int | Recombinant DNA molecule, transformed host organism, and method for producing interferon |
DK156072C (en) * | 1985-04-03 | 1989-11-06 | Nordisk Gentofte | SYNTHETIC DNA SEQUENCE CONTAINING A RIBO BINDING SITE |
DK151585D0 (en) * | 1985-04-03 | 1985-04-03 | Nordisk Gentofte | DNA sequence |
DE3514113A1 (en) * | 1985-04-19 | 1986-10-23 | Hoechst Ag, 6230 Frankfurt | CHANGE OF THE DNA SEQUENCE BETWEEN SHINE-DALGARNO SEQUENCE AND START CODON OF THE TRP OPERON TO INCREASE PROTEIN EXPRESSION |
US4874703A (en) * | 1985-08-26 | 1989-10-17 | Eli Lilly And Company | Expression vectors for use in E. coli |
DE3607835A1 (en) * | 1986-03-10 | 1987-09-24 | Boehringer Ingelheim Int | HYBRID INTERFERONS, THEIR USE AS MEDICINAL PRODUCTS AND AS INTERMEDIATE PRODUCTS FOR THE PRODUCTION OF ANTIBODIES AND THE USE THEREOF AND METHOD FOR THEIR PRODUCTION |
DE3642096A1 (en) * | 1986-12-10 | 1988-06-16 | Boehringer Ingelheim Int | HORSE (GAMMA) INTERFERON |
GB8813032D0 (en) * | 1988-06-02 | 1988-07-06 | Boehringer Ingelheim Int | Antiviral pharmaceutical composition |
WO1990005186A1 (en) * | 1988-11-04 | 1990-05-17 | The Upjohn Company | Somatotropin expression using a serratia promoter |
EP0626448A3 (en) * | 1993-05-26 | 1998-01-14 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Process for preparing and purifying alpha-interferon |
US5531880A (en) * | 1994-09-13 | 1996-07-02 | Microelectronics And Computer Technology Corporation | Method for producing thin, uniform powder phosphor for display screens |
FR2724665B1 (en) * | 1994-09-16 | 1996-12-20 | Rhone Poulenc Rorer Sa | PROCESS FOR PRODUCING RECOMBINANT PROTEINS, PLASMIDS AND MODIFIED CELLS |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA811368B (en) * | 1980-03-24 | 1982-04-28 | Genentech Inc | Bacterial polypedtide expression employing tryptophan promoter-operator |
EP0042246B1 (en) * | 1980-06-12 | 1987-03-18 | The Cancer Institute Of Japanese Foundation For Cancer Research | Plasmid |
ZA814375B (en) * | 1980-07-01 | 1982-07-28 | Hoffmann La Roche | Interferons and process for their preparation |
IE52755B1 (en) * | 1980-08-26 | 1988-02-17 | Univ California | Bovine pre-growth and growth hormone |
DE3280127D1 (en) * | 1981-03-27 | 1990-04-12 | Ici Plc | GENETICALLY MODIFIED MICROORGANISMS. |
DE3220116A1 (en) * | 1982-05-28 | 1983-12-01 | Dr. Karl Thomae Gmbh, 7950 Biberach | MICROBIOLOGICALLY MANUFACTURED (ALPHA) AND SS INTERFERONES, DNA SEQUENCES CODING FOR THESE INTERFERONES, MICROORGANISMS CONTAINING THIS GENETIC INFORMATION, AND METHOD FOR THE PRODUCTION THEREOF |
DE3247923A1 (en) * | 1982-12-24 | 1984-06-28 | Dr. Karl Thomae Gmbh, 7950 Biberach | Oligonucleotides and process for their preparation |
-
1982
- 1982-12-24 DE DE19823247922 patent/DE3247922A1/en not_active Withdrawn
-
1983
- 1983-12-02 GR GR73142A patent/GR78766B/el unknown
- 1983-12-14 DK DK576983A patent/DK576983A/en not_active Application Discontinuation
- 1983-12-20 EP EP83112812A patent/EP0115613B1/en not_active Expired - Lifetime
- 1983-12-20 DE DE8383112812T patent/DE3382233D1/en not_active Expired - Fee Related
- 1983-12-20 AT AT83112812T patent/ATE62018T1/en not_active IP Right Cessation
- 1983-12-21 FI FI834700A patent/FI86991C/en not_active IP Right Cessation
- 1983-12-22 ZA ZA839519A patent/ZA839519B/en unknown
- 1983-12-22 NZ NZ206700A patent/NZ206700A/en unknown
- 1983-12-22 HU HU834419A patent/HU202277B/en not_active IP Right Cessation
- 1983-12-22 DD DD83258476A patent/DD216043A5/en unknown
- 1983-12-22 IL IL70523A patent/IL70523A/en not_active IP Right Cessation
- 1983-12-23 SU SU833681952A patent/SU1366064A3/en active
- 1983-12-23 AU AU22832/83A patent/AU579991B2/en not_active Ceased
- 1983-12-23 UA UA3681952A patent/UA8035A1/en unknown
- 1983-12-23 JP JP58243626A patent/JPH088868B2/en not_active Expired - Lifetime
- 1983-12-23 ES ES528350A patent/ES528350A0/en active Granted
- 1983-12-23 NO NO834792A patent/NO173742C/en unknown
- 1983-12-23 KR KR1019830006147A patent/KR930005455B1/en not_active IP Right Cessation
-
1984
- 1984-06-07 ES ES533214A patent/ES533214A0/en active Granted
- 1984-06-07 ES ES533197A patent/ES533197A0/en active Granted
- 1984-06-07 ES ES533213A patent/ES533213A0/en active Granted
-
1985
- 1985-08-02 SU SU853935004A patent/SU1417800A3/en active
-
1992
- 1992-01-23 JP JP4009692A patent/JP2637328B2/en not_active Expired - Lifetime
- 1992-06-15 MX MX9202878A patent/MX9202878A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI86991B (en) | RECOMBINANT DNA SEQUENCER, DERASE FRAMSTAELLNING OCH DESSA SEQUENTOR INNEHAOLLANDE PLASMIDER. | |
Taniguchi et al. | Expression of the human fibroblast interferon gene in Escherichia coli. | |
EP0042246B1 (en) | Plasmid | |
ES8207514A1 (en) | Mature human leukocyte interferon A, process for its microbial preparation, intermediates therefor and compositions containing it. | |
DK305885A (en) | TUMORNECROSE FACTOR AND DERIVATIVES AND MUTANT FORMS THEREOF, FOR. FORWARD. THEREFORE, FORWARD. TO ISOLATED THEREOF FROM A MIXTURE WITH OTHER PROTEINS, PREPARATIONS THEREOF, THE DNA CODING THEREOF, THE DNA INCORPORATED IN A REPLICABLE VECTOR AND CELLS TRANSFORMED THEREOF | |
ES2122257T3 (en) | ANTHRAX TOXIN MELTING PROTEINS AND USES THEREOF. | |
ES8603574A1 (en) | Production of polypeptides with a human gamma-interferon activity. | |
DK440083D0 (en) | DNA SEQUENCES, RECOMBINATION DNA MOLECULES, AND PROCEDURES FOR PREPARING PIG GROWTH HORMONE-LIKE POLYPEPTIDES | |
NO175003C (en) | Fusion proteins with eukaryotic ballast fraction, vector containing a DNA encoding the fusion protein as well as E.coli cell containing the vector | |
FI971100A (en) | Process for producing recombinant DNA proteins, plasmids and modified cells | |
ATE163651T1 (en) | NEW HUMAN RECOMBINANT INTERFERON GAMMA | |
GR3019294T3 (en) | Plasmides, their preparation and their use in obtaining a plasminogen activator | |
ATE53606T1 (en) | RECOMBINANT PLASMID INSERTED WITH A HERPES SIMPLEX VIRUS GENE. | |
EP0072541A3 (en) | Human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them | |
ES2071108T3 (en) | EFFICIENT METHOD FOR IDENTIFIABLE EXPRESSION OF NON-SELECTABLE GENES. | |
GR3020035T3 (en) | Mammalian cell derived autonomously replicating sequence DNA fragments having affinity to DNA binding proteins | |
NO910331L (en) | RECOMBINANT PLASMID, PROCEDURE FOR ITS PREPARATION AND USE OF THE PLASMID IN THE PRODUCTION OF PROTEINS. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM | Patent lapsed | ||
MM | Patent lapsed |
Owner name: BOEHRINGER INGELHEIM INTERNATIONAL GMBH |